| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |